Back to Network
7
Shared Docs
7
Same-Page
7 / 7
Mentions
Document Mentions (7 shared documents)
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 134.01 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA2 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 100.25 5,000,000.00 EFTA01539621 5,012,500.00 4,725,000.00 287,500.00 96.87 1,000,000
2 mentions1 same-page
Page ?Same page
sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP
ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 02406P-AF-7 B /B2 CIT GROUP INC
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA2 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 02406P-AF-7 B /B2 Account Page 1
Sponsored
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 149.21 09062X-10-3 BIIB 21.66 30303M-10-2 FB Total US Large Cap Equity $1,091,957.30 $1,166,930.47 ($74,973
R AUG. @ 01% RATE ON NET AVG COLLECTED BALANCE OF $12,578,517.80 AS OF 09/01/12 GENERAL MOTORS CO CV PFD B @ 0.59375 PER SHARE (ID: 37045V-20-9) CIT GROUP INC 144A 7% MAY 02 2017 DTD 06/15/2011 (ID: 125581-GA-0) CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 (ID: 125581-FZ-6) BANC OF AMERICA FUNDING CORP
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 126.00 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
NY INC ACCT. For the Period 3/1/12 to 3/31/12 Price US Fixed Income AMERICAN AXLE & MFG INC 7 7/8% MAR 1 2017 DTD 2/27/2007 02406P-AF-7 B /B2 CIT GROUP INC 144A 7% MAY 02 2017 DTD 06/15/2011 125581-GA-0 BB- /B1 NRG ENERGY INC 7 5/8% JAN 15 2018 DTD 07/15/2011 629377-BN-1 BB- /B1 P PR CMWLTH PUBL
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 EFTA01539790 100.25 5,000,000.00 5,012,500.00 4,725,000.00 287,500.00 99.85 1,000,000
Sponsored
2 mentions1 same-page
Page ?Same page
e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A
ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC 6 1/2% FEB 15 2016 DTD 2/8/2006 404119-AR-0 B- /B3 CIT GROUP INC 144A 7% MAY 02 2016 JUN 15 2011 125581-FZ-6 BB- /B1 EFTA01539886 100.57 5,000,000.00 5,028,500.00 4,725,000.00 303,500.00 100.29 1,000,00
Sponsored
Mutual Connections (83)
Entities connected to both BIOGEN IDEC INC and CIT GROUP INC
JPMorgan Chase
ORGANIZATION16 w/ BIOGEN·122 w/ CIT
FORD MOTOR CREDIT CO LLC
ORGANIZATION2 w/ BIOGEN·114 w/ CIT
the Internal Revenue Service
ORGANIZATION9 w/ BIOGEN·105 w/ CIT
Paul Morris
PERSON7 w/ BIOGEN·99 w/ CIT
Newark
LOCATION9 w/ BIOGEN·87 w/ CIT
Securities Investor Protection Corporation
ORGANIZATION9 w/ BIOGEN·85 w/ CIT
PETROLEOS DE VENEZUELA S
ORGANIZATION7 w/ BIOGEN·70 w/ CIT
Ghislaine Maxwell
PERSON15 w/ BIOGEN·53 w/ CIT
Deutsche Bank
ORGANIZATION15 w/ BIOGEN·42 w/ CIT
UNCAPPED
ORGANIZATION12 w/ BIOGEN·44 w/ CIT
Bank of America
ORGANIZATION9 w/ BIOGEN·41 w/ CIT
FDIC
ORGANIZATION15 w/ BIOGEN·27 w/ CIT
Paul Barrett
PERSON15 w/ BIOGEN·22 w/ CIT
HCA INC
ORGANIZATION8 w/ BIOGEN·28 w/ CIT
Nassau
LOCATION8 w/ BIOGEN·25 w/ CIT
REC FIXED
ORGANIZATION3 w/ BIOGEN·22 w/ CIT
HB
Harry Beller
PERSON8 w/ BIOGEN·16 w/ CIT
CITIGROUP CAPITAL XIII
ORGANIZATION8 w/ BIOGEN·16 w/ CIT
NEW YORK NY
LOCATION8 w/ BIOGEN·15 w/ CIT
Barclays
ORGANIZATION11 w/ BIOGEN·11 w/ CIT